Vitamin B2 (Riboflavin) Market Size, Share, Growth, and Industry Analysis, By Type (Food Grade,Feed Grade,Pharmaceutical Grade), By Application (Pharmaceutical Industry,Food Industry,Feed Industry), Regional Insights and Forecast to 2035

Vitamin B2 (Riboflavin) Market Overview

The global Vitamin B2 (Riboflavin) Market size is projected to grow from USD 941.82 million in 2026 to USD 986.56 million in 2027, reaching USD 1429.96 million by 2035, expanding at a CAGR of 4.75% during the forecast period.

The Vitamin B2 (Riboflavin) Market involves industrial-scale production, formulation, and distribution of riboflavin for food fortification, pharmaceuticals, feed, and dietary supplements. Global annual production already exceeds 10,000 metric tons, with about 70 % used in animal feed, 20 % in food and beverage fortification, and 10 % in pharmaceutical and cosmetic uses.

In the United States, riboflavin is widely used in fortified cereals, dairy products, dietary supplements, and parenteral nutrition. Less than 6 % of the U.S. population has riboflavin intake below the Estimated Average Requirement (EAR) per NHANES data.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 70 % of manufactured riboflavin is used in feed applications globally.
• Major Market Restraint: 25 % of scale-up fermentation runs fail due to yield drop.
• Emerging Trends: 30 % of new riboflavin projects employ engineered microbial strains.
• Regional Leadership: Asia-Pacific leads, holding over 40 % share of production volume.
• Competitive Landscape: Top 4 manufacturers supply ~80 % of global riboflavin capacity.
• Market Segmentation: Feed grade riboflavin accounts for ~70 % usage share.
• Recent Development: In 2025, mutated strain yielded 5.5 mg/L riboflavin in lab fermentation.

Vitamin B2 (Riboflavin) Market Latest Trends

Current trends in the Vitamin B2 (Riboflavin) Market reflect advances in microbial strain engineering, process intensification, demand for fortified nutrition, and price stabilization. A key trend is the adoption of mutated microbial strains—for example, a Lactiplantibacillus pentosus SV13 mutant achieved 5.5 mg/L riboflavin production in optimized medium versus 2.8 mg/L baseline, nearly a 1.96-fold improvement.

Vitamin B2 (Riboflavin) Market Dynamics

The dynamics of the Vitamin B2 (Riboflavin) Market are influenced by rising feed demand, increasing food fortification programs, and expanding pharmaceutical usage, balanced against production challenges, regulatory complexities, and supply chain pressures. Globally, more than 70 % of riboflavin output is directed toward animal feed applications, where poultry, swine, and aquaculture account for the majority of consumption, while roughly 20 % is consumed by the food industry and about 10 % by pharmaceuticals.

DRIVER

"Rising demand in feed, fortified nutrition, and pharmaceutical usage."

Growth is propelled by expanding demand in animal feed: about 70 % of produced riboflavin goes into poultry, swine, and aquaculture feed because it enhances growth, feed conversion, and immunity. In human nutrition, fortification mandates in over 100 countries require inclusion of B-complex vitamins in staple foods.

RESTRAINT

"Scale-up complexity, raw material variability, and cost sensitivity."

While lab-scale performance is promising, nearly 25 % of scale-up fermentation runs face yield decline, contamination, or metabolic drift. Raw material inputs—such as glucose, yeast extract, nitrogen sources—vary in quality; fluctuations can cause 10–15 % yield drop. Enzyme supplementation, buffer systems, and cofactor supply can contribute 15–20 % of production cost.

OPPORTUNITY

"Strain innovation, retrofit of existing fermentation plants, and emerging market demand".

Opportunities abound in upgrading microbial strains—mutagenesis, metabolic engineering, and synthetic biology can push yields 1.5–2.5×. The example of SV13 strain improvement shows potential to nearly double output. Many existing fermentation plants used for amino acids or vitamins can be retrofitted to include riboflavin lines, reducing capital cost.

CHALLENGE

"Intellectual property, quality control, and regulatory compliance."

Riboflavin production involves proprietary strains, pathway patents, and licensing complexity; about 30 % of licensing agreements face patent disputes or royalty conflicts. Maintaining batch-to-batch consistency is demanding—deviations in purity, enantiomer ratio, or impurity profile must stay below tight thresholds (e.g., < 0.05 % impurities). Regulatory compliance across food, feed and pharmaceutical grades is rigorous, requiring validation, audits, and stability studies for more than 500 product SKUs.

Vitamin B2 (Riboflavin) Market Segmentation

The Vitamin B2 (Riboflavin) Market is segmented by type (Food Grade, Feed Grade, Pharmaceutical Grade) and application (Pharmaceutical, Food, Feed). Feed Grade dominates with ~70 % of volume share due to mass usage in animal nutrition. Food Grade accounts for ~20 % via fortification, while Pharmaceutical Grade covers ~10 % in high-purity therapeutic and parenteral forms.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Food Grade: Food Grade riboflavin is used for fortification of cereals, dairy, beverages, infant formulas, and health foods. It must meet purity standards (≥ 98 % assay, low impurities) and comply with food regulatory limits. Food Grade accounts for roughly 20 % of total volume.

The Food Grade Vitamin B2 segment of the global market is valued at USD 314.68 million in 2025 and is projected to reach USD 489.44 million by 2034, capturing a 35.0% market share with a consistent CAGR of 4.8%, strongly supported by widespread food fortification initiatives, expanding bakery applications, and growing consumer adoption of functional foods across diverse regions.

Top 5 Major Dominant Countries in the Food Grade Segment

• United States: The United States Food Grade Vitamin B2 market is valued at USD 94.40 million in 2025 and projected to reach USD 146.83 million by 2034, capturing a significant 30.0% share with 4.8% CAGR, strongly supported by nationwide flour fortification mandates, high consumer preference for functional foods, and expanding use of Vitamin B2 in processed bakery and cereal products.
• China: The China Food Grade Vitamin B2 market is estimated at USD 82.00 million in 2025 and forecast to reach USD 127.23 million by 2034, securing a 26.0% share with 4.8% CAGR, driven by government-backed food fortification programs, growing consumption of fortified dairy and beverage products, and expanding urban dietary supplementation trends in rapidly developing cities.
• India: The India Food Grade Vitamin B2 market is worth USD 63.00 million in 2025 and is expected to reach USD 97.74 million by 2034, accounting for a 20.0% share with 4.8% CAGR, supported by national nutrition programs, a rapidly growing bakery sector producing fortified goods, and increasing consumer awareness regarding dietary supplementation.
• Germany: The Germany Food Grade Vitamin B2 market is valued at USD 44.00 million in 2025 and forecast to grow to USD 68.26 million by 2034, holding a 14.0% share with 4.8% CAGR, supported by strict EU nutritional regulations, expansion of fortified cereals and bread categories, and consumer preference for health-focused food innovation.
• Brazil: The Brazil Food Grade Vitamin B2 market is valued at USD 31.20 million in 2025 and projected to reach USD 48.39 million by 2034, capturing a 10.0% share with 4.8% CAGR, supported by the expansion of fortified flour consumption, rising demand for processed foods, and national food security programs encouraging nutrition enhancement.

Feed Grade: Feed Grade riboflavin is the largest segment, making up about 70 % of global consumption by volume. It is used in poultry, swine, aquaculture, and livestock feed as a growth promoter and health enhancer. The manufacturing purity is slightly lower (e.g. 95–98% assay), and tolerances on impurities are relaxed relative to food/pharma grades.

The Feed Grade Vitamin B2 segment of the global market is valued at USD 449.56 million in 2025 and is projected to reach USD 682.56 million by 2034, accounting for the largest 50.0% market share with a steady CAGR of 4.7%, strongly supported by the rising demand for poultry, swine, and aquaculture feed formulations, as well as mandatory livestock nutritional standards across leading economies.

Top 5 Major Dominant Countries in the Feed Grade Segment

• China: The China Feed Grade Vitamin B2 market is valued at USD 134.86 million in 2025 and projected to grow to USD 204.77 million by 2034, securing a 30.0% share with 4.7% CAGR, supported by the world’s largest poultry and aquaculture feed production systems and extensive livestock sector investments.
• United States: The United States Feed Grade Vitamin B2 market is valued at USD 103.40 million in 2025 and forecast to reach USD 157.00 million by 2034, capturing a 23.0% share with 4.7% CAGR, supported by advanced swine feed demand, modern feed formulations, and robust livestock nutrition standards.
• India: The India Feed Grade Vitamin B2 market is worth USD 67.43 million in 2025 and expected to rise to USD 102.30 million by 2034, accounting for a 15.0% share with 4.7% CAGR, driven by rapid poultry sector expansion, aquaculture development, and government-led feed enrichment programs.
• Brazil: The Brazil Feed Grade Vitamin B2 market is valued at USD 53.95 million in 2025 and projected to reach USD 81.95 million by 2034, holding a 12.0% share with 4.7% CAGR, supported by strong poultry export activities, protein feed demand, and agricultural modernization initiatives.
• Germany: The Germany Feed Grade Vitamin B2 market is valued at USD 44.95 million in 2025 and forecast to grow to USD 68.25 million by 2034, representing a 10.0% share with 4.7% CAGR, driven by strict European Union feed nutrition standards and continued livestock feed innovation.

Pharmaceutical Grade: Pharmaceutical Grade riboflavin is used in injectable formulations, parenteral nutrition, therapeutic supplements, and high-purity capsules. This grade demands stringent impurity profiles, endotoxin limits, sterile filtration, GMP manufacturing, and validation. It represents only ~10 % of volume but captures high premium pricing.

The Pharmaceutical Grade Vitamin B2 segment of the global market is valued at USD 134.87 million in 2025 and is projected to reach USD 193.12 million by 2034, capturing a 15.0% market share with a CAGR of 4.7%, strongly supported by medical prescriptions, clinical applications, and the rising demand for nutraceutical formulations in preventive healthcare.

Top 5 Major Dominant Countries in the Pharmaceutical Grade Segment

• United States: The United States Pharmaceutical Grade Vitamin B2 market is valued at USD 40.46 million in 2025 and projected to grow to USD 57.94 million by 2034, capturing a 30.0% share with 4.7% CAGR, supported by widespread clinical prescriptions, growing nutraceutical demand, and pharmaceutical innovation.
• China: The China Pharmaceutical Grade Vitamin B2 market is estimated at USD 33.72 million in 2025 and forecast to reach USD 48.28 million by 2034, securing a 25.0% share with 4.7% CAGR, supported by strong supplement manufacturing capacity and rising preventive healthcare adoption.
• Germany: The Germany Pharmaceutical Grade Vitamin B2 market is valued at USD 20.23 million in 2025 and projected to hit USD 28.97 million by 2034, accounting for 15.0% share with 4.7% CAGR, driven by strict EU health supplement regulations and increasing demand for prescription formulations.
• India: The India Pharmaceutical Grade Vitamin B2 market is worth USD 16.18 million in 2025 and expected to rise to USD 23.18 million by 2034, capturing a 12.0% share with 4.7% CAGR, supported by strong generic pharmaceutical production and nutraceutical innovation.
• Japan: The Japan Pharmaceutical Grade Vitamin B2 market is valued at USD 13.49 million in 2025 and projected to grow to USD 19.35 million by 2034, securing a 10.0% share with 4.7% CAGR, supported by advanced pharmaceutical innovation and rising consumer health awareness.

BY APPLICATION

Pharmaceutical Industry: In pharmaceutical applications, riboflavin serves as an essential nutrient in vitamins, metabolic therapy, and parenteral nutrition. It supports redox reactions as FAD and FMN cofactors. Pharmaceutical demand spans oral tablets, intravenous preparations, and therapeutic supplements.

The Pharmaceutical Industry application of Vitamin B2 is valued at USD 179.82 million in 2025 and projected to reach USD 273.02 million by 2034, capturing a 20.0% share with a CAGR of 4.8%, supported by prescription drug formulations, nutraceuticals, and preventive healthcare supplements.

Top 5 Major Dominant Countries in the Pharmaceutical Industry Application

• United States: The United States Pharmaceutical Industry Vitamin B2 market is valued at USD 53.94 million in 2025 and projected to reach USD 81.90 million by 2034, holding a 30.0% share with 4.8% CAGR, supported by strong clinical demand and nutraceutical innovation.
• China: The China Pharmaceutical Industry Vitamin B2 market is estimated at USD 44.96 million in 2025 and forecast to hit USD 68.25 million by 2034, capturing a 25.0% share with 4.8% CAGR, supported by supplement production and healthcare system adoption.
• Germany: The Germany Pharmaceutical Industry Vitamin B2 market is valued at USD 26.97 million in 2025 and expected to reach USD 40.95 million by 2034, representing a 15.0% share with 4.8% CAGR, supported by regulatory standards and high prescription rates.
• India: The India Pharmaceutical Industry Vitamin B2 market is worth USD 21.58 million in 2025 and projected to reach USD 32.76 million by 2034, securing a 12.0% share with 4.8% CAGR, supported by generic drug manufacturing and nutraceutical demand.
• Japan: The Japan Pharmaceutical Industry Vitamin B2 market is valued at USD 17.98 million in 2025 and forecast to grow to USD 27.30 million by 2034, capturing a 10.0% share with 4.8% CAGR, supported by innovation in pharmaceuticals and consumer healthcare.

Food Industry: Food industry applications include fortification of staple foods, beverages, dairy, cereals, snack products, and functional foods. This application accounts for ~20 % of total riboflavin usage. In many markets, mandatory fortification policies require addition of B-complex vitamins including riboflavin to staple foods.

The Food Industry application of Vitamin B2 is valued at USD 269.73 million in 2025 and projected to reach USD 409.54 million by 2034, capturing a 30.0% share with a CAGR of 4.8%, supported by bakery fortification, dairy supplements, and cereal-based nutritional programs.

Top 5 Major Dominant Countries in the Food Industry Application

• United States: The United States Food Industry Vitamin B2 market is valued at USD 80.92 million in 2025 and projected to hit USD 122.86 million by 2034, securing a 30.0% share with 4.8% CAGR, supported by fortified flour and cereals.
• China: The China Food Industry Vitamin B2 market is worth USD 70.13 million in 2025 and forecast to reach USD 106.48 million by 2034, accounting for a 26.0% share with 4.8% CAGR, supported by growing fortified beverages and dairy demand.
• India: The India Food Industry Vitamin B2 market is valued at USD 53.95 million in 2025 and expected to grow to USD 81.90 million by 2034, representing a 20.0% share with 4.8% CAGR, supported by bakery growth and government fortification programs.
• Germany: The Germany Food Industry Vitamin B2 market is estimated at USD 37.76 million in 2025 and projected to reach USD 57.34 million by 2034, holding a 14.0% share with 4.8% CAGR, supported by EU nutrition standards and fortified food categories.
• Brazil: The Brazil Food Industry Vitamin B2 market is valued at USD 26.97 million in 2025 and forecast to hit USD 40.95 million by 2034, capturing a 10.0% share with 4.8% CAGR, supported by fortified flour and processed food adoption.

Feed Industry: The feed industry is the dominant application, consuming ~70 % of all riboflavin volume. It is included in feed premixes for poultry, swine, ruminants, and aquaculture to support growth, egg production, fertility, and health. Riboflavin improves feed conversion and reduces oxidative stress in livestock.

The Feed Industry application of Vitamin B2 is valued at USD 449.56 million in 2025 and projected to reach USD 682.56 million by 2034, accounting for the largest 50.0% share with a CAGR of 4.7%, strongly supported by poultry, swine, and aquaculture nutrition demand.

Top 5 Major Dominant Countries in the Feed Industry Application

• China: The China Feed Industry Vitamin B2 market is valued at USD 134.86 million in 2025 and forecast to reach USD 204.77 million by 2034, capturing a 30.0% share with 4.7% CAGR, driven by massive livestock and aquaculture feed programs.
• United States: The United States Feed Industry Vitamin B2 market is valued at USD 103.40 million in 2025 and projected to hit USD 157.00 million by 2034, securing a 23.0% share with 4.7% CAGR, supported by swine feed and advanced livestock systems.
• India: The India Feed Industry Vitamin B2 market is worth USD 67.43 million in 2025 and forecast to grow to USD 102.30 million by 2034, capturing a 15.0% share with 4.7% CAGR, supported by poultry sector expansion and feed modernization.
• Brazil: The Brazil Feed Industry Vitamin B2 market is valued at USD 53.95 million in 2025 and projected at USD 81.95 million by 2034, holding a 12.0% share with 4.7% CAGR, supported by poultry exports and feed enrichment.
• Germany: The Germany Feed Industry Vitamin B2 market is valued at USD 44.95 million in 2025 and expected to reach USD 68.25 million by 2034, securing a 10.0% share with 4.7% CAGR, supported by EU livestock feed standards.

Regional Outlook for the Vitamin B2 (Riboflavin) Market

Regional performance shows Asia-Pacific as the fastest-growing and highest-volume region in riboflavin production and consumption with > 40 % share in many forecasts. North America maintains strong demand in feed, pharma, and food fortification, with high per-ton price benchmarks. Europe supports mature markets for fortified foods, supplements, and regulatory alignment.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

In North America, riboflavin demand is robust across feed, food fortification, and pharmaceutical channels. The region often commands one of the highest spot price benchmarks—U.S. New Jersey reached USD 39,700/ton in June 2025 with a 0.25 % monthly increase. The feed industry in the U.S. consumes large volumes, with feed premix companies procuring multi-year riboflavin contracts.

The North America Vitamin B2 (Riboflavin) Market is valued at USD 260.74 million in 2025 and is projected to reach USD 398.58 million by 2034, capturing a 29.0% share with a CAGR of 4.7%, strongly supported by the rising prevalence of food fortification programs, a mature pharmaceutical market with over 200 prescription formulations, and increasing livestock feed adoption across the U.S., Canada, and Mexico.

North America – Major Dominant Countries in the Vitamin B2 (Riboflavin) Market

• United States: The U.S. Vitamin B2 market is valued at USD 182.52 million in 2025 and forecast to grow to USD 278.32 million by 2034, capturing a dominant 70.0% share with 4.7% CAGR, supported by nationwide flour fortification, clinical prescriptions, and feed nutrition standards.
• Canada: The Canada Vitamin B2 market is estimated at USD 39.11 million in 2025 and projected to reach USD 59.79 million by 2034, securing a 15.0% share with 4.7% CAGR, driven by food industry fortification and nutraceutical innovation.
• Mexico: The Mexico Vitamin B2 market is valued at USD 26.07 million in 2025 and forecast to reach USD 39.86 million by 2034, capturing a 10.0% share with 4.7% CAGR, supported by fortified flour adoption and feed enrichment programs.
• Cuba: The Cuba Vitamin B2 market is estimated at USD 7.82 million in 2025 and projected to grow to USD 11.95 million by 2034, holding a 3.0% share with 4.7% CAGR, supported by food security nutrition initiatives.
• Puerto Rico: The Puerto Rico Vitamin B2 market is valued at USD 5.22 million in 2025 and expected to hit USD 7.66 million by 2034, securing a 2.0% share with 4.7% CAGR, supported by fortified cereals and dietary supplement imports.

EUROPE

Europe remains a mature and stable region for riboflavin usage and innovation. Countries such as Germany, France, UK, Italy, and the Netherlands host many fortified food programs and robust feed industries. European regulatory standards for food, feed, and pharmaceuticals enforce strict purity and safety norms that riboflavin suppliers must meet, including GMO, residual solvents, and microbial limits.

The Europe Vitamin B2 (Riboflavin) Market is valued at USD 242.76 million in 2025 and projected to reach USD 371.55 million by 2034, accounting for a 27.0% share with a CAGR of 4.7%, supported by strong EU regulations mandating flour fortification, robust demand for nutraceuticals, and wide adoption in livestock feed across Germany, France, and the United Kingdom.

Europe – Major Dominant Countries in the Vitamin B2 (Riboflavin) Market

• Germany: The Germany Vitamin B2 market is valued at USD 72.83 million in 2025 and expected to grow to USD 111.47 million by 2034, capturing 30.0% share with 4.7% CAGR, supported by EU feed standards and fortified cereal consumption.
• France: The France Vitamin B2 market is estimated at USD 58.26 million in 2025 and projected at USD 89.00 million by 2034, holding a 24.0% share with 4.7% CAGR, supported by fortified bakery demand and nutraceutical expansion.
• United Kingdom: The U.K. Vitamin B2 market is valued at USD 48.55 million in 2025 and forecast to reach USD 74.15 million by 2034, securing a 20.0% share with 4.7% CAGR, supported by prescription pharmaceuticals and fortified cereals.
• Italy: The Italy Vitamin B2 market is worth USD 36.41 million in 2025 and expected to hit USD 55.73 million by 2034, capturing 15.0% share with 4.7% CAGR, supported by bakery sector growth and fortified pasta production.
• Spain: The Spain Vitamin B2 market is valued at USD 26.99 million in 2025 and projected to grow to USD 41.20 million by 2034, accounting for 11.0% share with 4.7% CAGR, supported by fortified flour initiatives and animal feed applications.

ASIA-PACIFIC

Asia-Pacific is the fastest-expanding and highest-volume region for the riboflavin market. China, India, Japan, South Korea, and Southeast Asia countries host numerous fermentation plants and feed premix operations. China has become a global export hub, providing a significant share of global riboflavin supply. Many Asian feed industries integrate riboflavin into poultry, swine, aquaculture, and cattle diets at scale. Food fortification policies in India, Indonesia, and Vietnam amplify demand for food-grade riboflavin.

The Asia Vitamin B2 (Riboflavin) Market is valued at USD 323.68 million in 2025 and projected to reach USD 497.87 million by 2034, capturing the largest 36.0% share with the fastest CAGR of 4.7%, supported by rapid population growth, strong feed industry expansion, and government-led food fortification programs across China, India, and Japan.

Asia – Major Dominant Countries in the Vitamin B2 (Riboflavin) Market

• China: The China Vitamin B2 market is valued at USD 129.47 million in 2025 and forecast to reach USD 199.15 million by 2034, capturing a dominant 40.0% share with 4.7% CAGR, supported by feed expansion and fortified foods.
• India: The India Vitamin B2 market is valued at USD 97.10 million in 2025 and projected to hit USD 149.44 million by 2034, securing 30.0% share with 4.7% CAGR, supported by bakery growth and government nutrition mandates.
• Japan: The Japan Vitamin B2 market is estimated at USD 48.55 million in 2025 and forecast to grow to USD 74.15 million by 2034, holding 15.0% share with 4.7% CAGR, supported by nutraceutical adoption and advanced pharmaceuticals.
• South Korea: The South Korea Vitamin B2 market is worth USD 32.36 million in 2025 and expected to reach USD 49.41 million by 2034, capturing 10.0% share with 4.7% CAGR, supported by fortified beverages and livestock feed.
• Indonesia: The Indonesia Vitamin B2 market is valued at USD 16.20 million in 2025 and projected to grow to USD 26.19 million by 2034, representing 5.0% share with 4.7% CAGR, supported by poultry feed and fortified processed foods.

MIDDLE EAST & AFRICA

In Middle East & Africa, riboflavin demand is smaller in absolute volumes but growing. Feed market expansion—especially poultry and aquaculture in countries like Saudi Arabia, UAE, Nigeria, and South Africa—increases riboflavin uptake. Governments are initiating food fortification mandates for staple foods in several African nations, creating incremental food-grade riboflavin demand.

The Middle East & Africa Vitamin B2 (Riboflavin) Market is valued at USD 71.93 million in 2025 and projected to reach USD 97.12 million by 2034, accounting for a 8.0% share with a CAGR of 4.7%, supported by expanding food fortification programs, livestock sector growth, and increasing demand for fortified flour in Gulf and African nations.

Middle East & Africa – Major Dominant Countries in the Vitamin B2 (Riboflavin) Market

• Saudi Arabia: The Saudi Arabia Vitamin B2 market is valued at USD 21.58 million in 2025 and projected to reach USD 29.13 million by 2034, capturing 30.0% share with 4.7% CAGR, supported by fortified flour and animal feed growth.
• United Arab Emirates: The UAE Vitamin B2 market is valued at USD 17.98 million in 2025 and forecast to hit USD 24.28 million by 2034, securing 25.0% share with 4.7% CAGR, supported by bakery fortification and pharmaceutical imports.
• South Africa: The South Africa Vitamin B2 market is estimated at USD 12.94 million in 2025 and projected at USD 17.46 million by 2034, holding 18.0% share with 4.7% CAGR, supported by feed sector expansion and fortified cereals.
• Egypt: The Egypt Vitamin B2 market is worth USD 11.50 million in 2025 and expected to grow to USD 15.50 million by 2034, capturing 16.0% share with 4.7% CAGR, supported by government nutrition initiatives and bakery fortification.
• Nigeria: The Nigeria Vitamin B2 market is valued at USD 8.63 million in 2025 and forecast to hit USD 11.75 million by 2034, representing 11.0% share with 4.7% CAGR, supported by poultry feed enrichment and fortified flour demand.

List of Top Vitamin B2 (Riboflavin) Companies

• Xinfa Pharmaceutical
• BASF
• Hegno
• Shanxi Jixiang Biological Engineering
• NB GROUP
• Hubei Guangji Pharmaceutical
• Ningxia Qiyuan Pharmaceutical
• DSM
• Acebright Pharmaceuticals Group

Hubei Guangji Pharmaceutical: commands approximately 20–25 % of global riboflavin production, particularly in feed and food grade segments.

BASF: holds around 15–20 % share in global riboflavin licensing, supply, and process technology across grades.

Investment Analysis and Opportunities

Investment in the Vitamin B2 (Riboflavin) Market centers on strain R&D, fermentation scale-up, downstream formulation, and geographic capacity expansion. In 2023–2025 several riboflavin producers committed to upgrades in yield, productivity, and control systems, investing millions in pilot plants and process intensification.

New Product Development

Recent product development in riboflavin focuses on novel microbial strains, improved formulations, co-factor derivatives, and encapsulation systems. In 2025, scientists reported a mutated strain producing 5.5 mg/L riboflavin (versus 2.8 mg/L in wild type), nearly doubling yield under lab fermentation using optimized media with arabinose carbon source.

Five Recent Developments

• In 2025, a mutant strain of Lactiplantibacillus pentosus SV13 achieved 5.5 mg/L riboflavin production, nearly doubling the output vs. baseline strains.
• In 2025, U.S. New Jersey spot price reached USD 39,700/ton, rising 0.25 % month-on-month.
• In 2025 Q2, Shanghai spot price for riboflavin reached USD 37,250/ton, up 0.27 % sequentially.
• In 2024, top producers consolidated through a licensing deal covering proprietary strains across Asia, capturing ~80 % of supply.
• In 2024, price stability observed: no major production halts or logistics disruptions, enabling steady procurement in feed, food, and pharma sectors.

Report Coverage of Vitamin B2 (Riboflavin) Market

The Vitamin B2 (Riboflavin) Market Report offers a comprehensive treatment of global and regional dynamics, historical data, and forward-looking forecasts through 2034. Coverage spans production volumes (>10,000 tons/year), price trends, supply-demand balances, and segmentation by type (Food Grade, Feed Grade, Pharmaceutical Grade) and application (Feed, Food, Pharmaceutical). The report’s regional chapters include North America, Europe, Asia-Pacific, Middle East & Africa, each with country-level breakdowns, share projections, and market drivers.

Vitamin B2 (Riboflavin) Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 941.82 Million in 2026
Market Size Value By	USD 1429.96 Million by 2035
Growth Rate	CAGR of 4.75% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Food Grade Feed Grade Pharmaceutical Grade By Application : Pharmaceutical Industry Food Industry Feed Industry
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample